ARVN FY 2025 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$907M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$263M-0.3% YoY

Gross Profit

$257M98.0% margin

Operating Income

-$115M-43.8% margin

Net Income

-$81M-30.8% margin

EPS (Diluted)

$-1.28

Cash Flow

Operating Cash Flow

-$274M

Free Cash Flow

-$276M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$718M

Total Liabilities

$284M

Stockholders' Equity

$434M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$263M	$263M	-0.3%
Gross Profit	$257M	$263M	-2.3%
Operating Income	-$115M	-$250M	+54.1%
Net Income	-$81M	-$199M	+59.4%